Our study presents a novel and effective strategy for the in vitro evolution and characterization of trans-acting RNA-cleaving DNAzymes specifically targeting the BCL-2 mRNA—a key anti-apoptotic gene that is overexpressed in many human cancers. Here, BCL2 is linked to cancer.